Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
-
Vislink Reports Second Quarter 2024 Financial and Operational Results
-
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
-
Blackford Capital Named to 2024 Inc. 5000 List as One of America’s Fastest Growing Companies
-
Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
-
Polar Power Reports Second Quarter 2024 Financial Results
-
Xcel Brands, Inc. Announces Second Quarter 2024 Results
-
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody
-
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
-
HYLA Division Amplifies Reach with Expanded Multi-Million Dollar Distribution Network in Eastern Europe
-
Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board
-
Accredited Solutions Initiates Uplisting Process to OTCQB
-
Horizon Media Taps Comscore as Preferred Contextual Intelligence Provider to Tackle Signal Loss and Privacy Challenges
-
Applied Digital Strengthens Security Leadership with Appointment of Industry Veteran Gary Smith
-
Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device
-
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™
-
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
-
Importers Continue Shift to Mexico Amid Political Changes and Altering Market Dynamics, States Redwood’s Cross-Border Index
-
ScribeAmerica Announces Expansion of Speke AI Service Line
-
Calibre Scientific Acquires Greyhound Chromatography, a UK Provider of Analytical Standards and Chromatography Consumables
-
Quadient Recognized as a Major Player for First Time in IDC MarketScape for Worldwide Accounts Payable Automation Software for Midmarket and Small Businesses
-
Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
-
Fairfax Announces Acquisition of Additional Ensign Energy Services Inc. Common Shares
-
Clearlight’s Countdown to Wellness—Gifts That Shine Bright This Holiday Season
-
Terranet invites to presentation of Q2 report on August 15, 2024
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
The Dawn Project Slams Silicon Valley for peddling “Snake Oil” AI in Full-Page Wall Street Journal and New York Times Ads
-
Form 8.3 - [IQGEO GROUP PLC - 13 08 2024] - (CGAML)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 13 08 2024] - (CGWL)
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
-
Alliance Trust PLC - Net Asset Value
-
Base Carbon Reports Second-Quarter 2024 Operating and Financial Results
-
Trinity Biotech Announces Q2 2024 Financial Results
-
Prime Drink Group Corp. Enters Into a Final Share Purchase Agreement to Acquire Triani Canada Inc.
-
Dundee Corporation Announces the Redemption of its Series 2 and Series 3 Preference Shares
-
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
-
Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005
-
Titan Further Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Further Extension of 2024 Annual General and Special Meeting
-
Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Pa
-
Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
-
WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date
-
FitLife Brands Announces Second Quarter 2024 Results
-
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
-
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 12 08 2024] - (CGWL)
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Dada to Announce Unaudited Second Quarter 2024 Financial Results on August 20, 2024
-
Girls Club Token $GIRLS Is Here to Break up Crypto’s Old Boy Network
